![Silvano Cominelli](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Silvano Cominelli
Algemeen Directeur bij GianCom AG
Profiel
Silvano Cominelli is currently the Chief Executive Officer & Chief Investment Officer at GianCom AG and also serves as the Chief Investment Advisor at ARMADA Investment AG.
Previously, he worked as a Director at Broncus Technologies, Inc. from 2007 to 2013, and as a Director at Pelikan Technologies, Inc. He also served as the Director-Neurology Business Unit at Serono SA from 1998 to 2000 and as an Investment Advisor at HBM Partners AG (Investment Management).
Dr. Cominelli holds a doctorate degree from the University of Zurich, which he received in 1999.
Actieve functies van Silvano Cominelli
Bedrijven | Functie | Begin |
---|---|---|
GianCom AG
![]() GianCom AG Investment ManagersFinance GianCom AG is an independent asset management firm headquartered in Zurich, Switzerland. The firm was founded in 2017 as Acoro Asset Management AG. GianCom manages a global fundamental, concentrated long-short equity fund for various types of investors. | Algemeen Directeur | 20-09-2017 |
ARMADA Investment AG
![]() ARMADA Investment AG Investment ManagersFinance ARMADA Investment AG (Armada) is an independent Swiss venture capital firm headquartered in Küsnacht, Switzerland. It was founded by Daniel S. Aegerter in 2000, after he led the merger between his US-based company, TRADEX Technologies and Ariba. | Private Equity Investor | - |
Eerdere bekende functies van Silvano Cominelli
Bedrijven | Functie | Einde |
---|---|---|
Broncus Technologies, Inc.
![]() Broncus Technologies, Inc. Medical SpecialtiesHealth Technology Broncus Technologies is a medical technology company focused on developing and commercializing innovative solutions for lung diseases. With LungPoint™, physicians plan bronchoscopic procedures and navigate to locations in the lungs accurately and quickly. Its line of Yield™ catheters are used to obtain tissue samples and detect blood vessels. Its patented treatment method, Airway Bypass using Exhale® Drug-Eluting Stents, is being investigated to determine if it can provide the first minimally-invasive treatment option for homogeneous, or diffuse, emphysema, the form of the disease experienced by the majority of emphysema patients. | Directeur/Bestuurslid | 01-02-2013 |
Serono SA
![]() Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Corporate Officer/Principal | 01-12-2000 |
HBM Partners AG (Investment Management)
![]() HBM Partners AG (Investment Management) Investment ManagersFinance HBM Partners AG (Investment Management) (HBM-IM) is the asset management division of HBM Partners AG. The firm is headquartered in Zug and was founded in 2001. HBM-IM provides investment advisory services to private companies. They manage the fund HBM Healthcare Investments. | Analyst-Equity | - |
Pelikan Technologies, Inc.
![]() Pelikan Technologies, Inc. Medical SpecialtiesHealth Technology Pelikan Technologies, Inc. develops hand held diagnostic and monitoring devices. It combines novel and proprietary blood sampling and measurement techniques with state-of-the-art miniaturization and automation technologies to develop superior hand-held medical diagnostic and monitoring devices. The company was founded in 2001 and is headquartered in Palo Alto, CA. | Directeur/Bestuurslid | - |
Opleiding van Silvano Cominelli
University of Zurich | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 6 |
---|---|
Pelikan Technologies, Inc.
![]() Pelikan Technologies, Inc. Medical SpecialtiesHealth Technology Pelikan Technologies, Inc. develops hand held diagnostic and monitoring devices. It combines novel and proprietary blood sampling and measurement techniques with state-of-the-art miniaturization and automation technologies to develop superior hand-held medical diagnostic and monitoring devices. The company was founded in 2001 and is headquartered in Palo Alto, CA. | Health Technology |
Broncus Technologies, Inc.
![]() Broncus Technologies, Inc. Medical SpecialtiesHealth Technology Broncus Technologies is a medical technology company focused on developing and commercializing innovative solutions for lung diseases. With LungPoint™, physicians plan bronchoscopic procedures and navigate to locations in the lungs accurately and quickly. Its line of Yield™ catheters are used to obtain tissue samples and detect blood vessels. Its patented treatment method, Airway Bypass using Exhale® Drug-Eluting Stents, is being investigated to determine if it can provide the first minimally-invasive treatment option for homogeneous, or diffuse, emphysema, the form of the disease experienced by the majority of emphysema patients. | Health Technology |
Serono SA
![]() Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Health Technology |
HBM Partners AG (Investment Management)
![]() HBM Partners AG (Investment Management) Investment ManagersFinance HBM Partners AG (Investment Management) (HBM-IM) is the asset management division of HBM Partners AG. The firm is headquartered in Zug and was founded in 2001. HBM-IM provides investment advisory services to private companies. They manage the fund HBM Healthcare Investments. | Finance |
GianCom AG
![]() GianCom AG Investment ManagersFinance GianCom AG is an independent asset management firm headquartered in Zurich, Switzerland. The firm was founded in 2017 as Acoro Asset Management AG. GianCom manages a global fundamental, concentrated long-short equity fund for various types of investors. | Finance |
ARMADA Investment AG
![]() ARMADA Investment AG Investment ManagersFinance ARMADA Investment AG (Armada) is an independent Swiss venture capital firm headquartered in Küsnacht, Switzerland. It was founded by Daniel S. Aegerter in 2000, after he led the merger between his US-based company, TRADEX Technologies and Ariba. | Finance |